Pharmacology of acamprosate: an overview.
In the last years important advances have been made in the development of drugs for the treatment of alcohol addiction. Acamprosate (calcium bis-acetylhomotaurine) is one of the better established drugs in this field on the European market. This review focuses first on the pharmacokinetics of acamprosate. The published data and the recent advances in our knowledge on the mechanisms involved in the intestinal absorption and elimination of this drug are summarized. The importance of pharmacokinetics for the proper clinical use of acamprosate is highlighted. The anti-relapse as well as the well-known effects of acamprosate on ethanol intake are discussed. The recent experiments in animal models of conditioned withdrawal are reviewed. These experiments, explored for the first time the anticraving effect of the drug. Finally, the proposed hypotheses on the neuropharmacological mechanism of action of acamprosate are discussed. The discussion deals with the relative importance of various hypotheses as well as with the recent experiments that support them. It is pointed out that further research is necessary in order to clearly understand the mode of action of acamprosate as well as the neurobiological mechanisms involved in alcohol dependence.
Zornoza
Teodoro
T
Department of Pharmaceutics, Faculty of Pharmacy, University of Valencia, Spain.
Cano
María J
MJ
Polache
Ana
A
Granero
Luis
L
D000077443:Acamprosate; D000427:Alcohol Deterrents / Q000493:pharmacokinetics / Q000494:pharmacology; D000437:Alcoholism / Q000188:drug therapy* / Q000517:prevention & control; D000818:Animals; D001682:Biological Availability; D006801:Humans; D007408:Intestinal Absorption; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D013654:Taurine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology
D000427:Alcohol Deterrents; D016194:Receptors, N-Methyl-D-Aspartate; D013654:Taurine; D000077443:Acamprosate